HIGHLIGHTS
- who: Samatha Sonnappa and collaborators from the University of Colorado Denver, Denver, Colorado, United States of America, Pulmonary and Critical Care have published the paper: Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0178112]. June 15, 2017 of February/23,/2017
SUMMARY
Of note, the improvements in obstructive lung disease symptoms and quality of life tend to be better with efBDP than fine-particle BDP at twice the dose,[35 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.